Lithuania will contribute to the global efforts to develop a vaccine against COVID-19


2020 05 07


The Government has approved of the allocation of at least EUR 100 000 for the development of a COVID-19 vaccine and ensuring universal access to it. Alongside the previously donated EUR 100 000 to the International Federation of Red Cross and Red Crescent Societies, Lithuania is thereby contributing to the fundraising initiative by President of the European Commission Ursula von der Leyen and several global organizations in response to COVID-19, donating funds to the Coalition for Epidemic Preparedness Innovations (CEPI).

The European Commission and international partners expect to raise more than EUR 7.5 billion by 23 May for the development of and universal access to the coronavirus vaccine.

Lithuania had previously been actively involved in the fight against COVID-19 and had allocated funds for research in this area. The Research Council of Lithuania and the Agency for Science, Innovation and Technology have launched national calls for development of research and innovative solutions in the field of COVID-19 (worth EUR 2.7 million). The measures funded are expected to contribute to the common EU response to COVID-19.

Senior officials from 43 countries, heads of international organisations and financial institutions as well as foundation, industry and other field representatives attended the event held on 4 May. Lithuania was represented by Minister of Health Aurelijus Veryga, who attended the event virtually.

This year, Lithuania has provided support to Italy, Spain, China (through the Red Cross Organization), Armenia, Ukraine, Georgia and Moldova to combat the COVID-19 epidemic.